Edwards Lifesciences Operating Margin 2006-2021 | EW
For a detailed definition, formula and example for Operating Margin, check out our new background page here.
Current and historical operating margin for Edwards Lifesciences (EW) over the last 10 years. The current operating profit margin for Edwards Lifesciences as of June 30, 2021 is 28.03%.
| Edwards Lifesciences Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2021-06-30 |
$4.93B |
$1.64B |
33.19% |
| 2021-03-31 |
$4.48B |
$0.92B |
20.63% |
| 2020-12-31 |
$4.39B |
$0.90B |
20.45% |
| 2020-09-30 |
$4.37B |
$0.86B |
19.62% |
| 2020-06-30 |
$4.32B |
$0.79B |
18.35% |
| 2020-03-31 |
$4.48B |
$1.23B |
27.45% |
| 2019-12-31 |
$4.35B |
$1.15B |
26.38% |
| 2019-09-30 |
$4.15B |
$0.83B |
20.01% |
| 2019-06-30 |
$3.97B |
$0.79B |
19.82% |
| 2019-03-31 |
$3.82B |
$0.77B |
20.15% |
| 2018-12-31 |
$3.72B |
$0.75B |
20.11% |
| 2018-09-30 |
$3.64B |
$1.06B |
29.13% |
| 2018-06-30 |
$3.55B |
$1.04B |
29.24% |
| 2018-03-31 |
$3.45B |
$1.04B |
30.02% |
| 2017-12-31 |
$3.44B |
$1.09B |
31.74% |
| 2017-09-30 |
$3.32B |
$0.96B |
28.86% |
| 2017-06-30 |
$3.23B |
$0.92B |
28.58% |
| 2017-03-31 |
$3.15B |
$0.89B |
28.25% |
| 2016-12-31 |
$2.96B |
$0.78B |
26.43% |
| 2016-09-30 |
$2.87B |
$0.79B |
27.46% |
| 2016-06-30 |
$2.74B |
$0.75B |
27.27% |
| 2016-03-31 |
$2.60B |
$0.68B |
26.14% |
| 2015-12-31 |
$2.49B |
$0.64B |
25.78% |
| 2015-09-30 |
$2.44B |
$0.62B |
25.32% |
| 2015-06-30 |
$2.43B |
$0.59B |
24.34% |
| 2015-03-31 |
$2.39B |
$0.56B |
23.60% |
| 2014-12-31 |
$2.32B |
$0.49B |
21.23% |
| 2014-09-30 |
$2.24B |
$0.47B |
21.03% |
| 2014-06-30 |
$2.13B |
$0.45B |
21.00% |
| 2014-03-31 |
$2.07B |
$0.46B |
21.97% |
| 2013-12-31 |
$2.05B |
$0.47B |
23.12% |
| 2013-09-30 |
$2.02B |
$0.49B |
24.16% |
| 2013-06-30 |
$1.97B |
$0.48B |
24.19% |
| 2013-03-31 |
$1.94B |
$0.45B |
23.03% |
| 2012-12-31 |
$1.90B |
$0.42B |
22.12% |
| 2012-09-30 |
$1.82B |
$0.36B |
20.01% |
| 2012-06-30 |
$1.78B |
$0.33B |
18.44% |
| 2012-03-31 |
$1.73B |
$0.31B |
17.77% |
| 2011-12-31 |
$1.68B |
$0.30B |
17.87% |
| 2011-09-30 |
$1.64B |
$0.29B |
17.92% |
| 2011-06-30 |
$1.58B |
$0.30B |
19.09% |
| 2011-03-31 |
$1.51B |
$0.30B |
19.85% |
| 2010-12-31 |
$1.45B |
$0.29B |
19.70% |
| 2010-09-30 |
$1.40B |
$0.27B |
19.19% |
| 2010-06-30 |
$1.38B |
$0.26B |
18.78% |
| 2010-03-31 |
$1.35B |
$0.25B |
18.37% |
| 2009-12-31 |
$1.32B |
$0.24B |
18.07% |
| 2009-09-30 |
$1.29B |
$0.23B |
17.96% |
| 2009-06-30 |
$1.26B |
$0.22B |
17.17% |
| 2009-03-31 |
$1.26B |
$0.21B |
16.40% |
| 2008-12-31 |
$1.24B |
$0.20B |
15.98% |
| 2008-09-30 |
$1.22B |
$0.19B |
15.22% |
| 2008-06-30 |
$1.18B |
$0.18B |
15.27% |
| 2008-03-31 |
$1.12B |
$0.18B |
15.57% |
| 2007-12-31 |
$1.09B |
$0.17B |
15.86% |
| 2007-09-30 |
$1.06B |
$0.17B |
16.17% |
| 2007-06-30 |
$1.05B |
$0.18B |
16.67% |
| 2007-03-31 |
$1.04B |
$0.17B |
16.67% |
| 2006-12-31 |
$1.04B |
$0.17B |
16.78% |
| 2006-09-30 |
$1.02B |
$0.18B |
17.34% |
| 2006-06-30 |
$1.02B |
$0.18B |
17.34% |
| 2006-03-31 |
$1.01B |
$0.18B |
17.50% |
| 2005-12-31 |
$1.00B |
$0.17B |
17.43% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$74.843B |
$4.386B |
|
Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.
|
